The Lupus Research Alliance has awarded grants to seven projects in the U.S. and Europe that seek to advance disease knowledge and treatment.| Lupus News Today
No systemic lupus erythematosus patient receiving the CAR T-cell therapy infusion relapsed, all remained in remission for up to 17 months.| Lupus News Today
Inflammatory macrophages, particularly M1-like macrophages, may be cause of more severe pediatric lupus nephritis, study says.| Lupus News Today
NKT cell activators hold promise for potential systemic lupus erythematosus (SLE) treatment, preclinical data show.| Lupus News Today
Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.| Lupus News Today
